Latest filing published 10 Dec 2009 for Theriva Biologics, Inc., €6,482.
Insider track record
No signal scores available.
Lyman Max Lyon Jr.: trading record in brief
Lyman Max Lyon Jr. is a declared insider of Theriva Biologics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 7 December 2009 to 9 December 2009, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 10 December 2009 with a transaction (€6,482) in Theriva Biologics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lyman Max Lyon Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$0.4763Common StockSEC:0000890163-09-000064:0
- 25,000 shares@ US$0.4502Common StockSEC:0000890163-09-000064:1
- 45,000 shares@ US$0.38Common StockSEC:0000890163-09-000062:0
3 of 3 declarations